Medline Inc. is 44.3x more valuable than TANDEM DIABETES CARE INC by market capitalization ($49.12 B vs $1.11 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | TNDM | MDLN |
|---|---|---|
| Market cap | $1.11 B | $49.12 B |
| US-listed rank | #2566 | #322 |
| Revenue (latest FY) | $1.01B | $28.43B |
| Net income (latest FY) | -$204.70M | $1.16T |
| Net margin | -20.2% | 4069.4% |
| P/E (trailing FY) | - | 0.0 |
| SEC filings | 1,234 | 103 |
Medline Inc. is 44.3x more valuable than TANDEM DIABETES CARE INC by market capitalization ($49.12 B vs $1.11 B).
In their latest fiscal years, TANDEM DIABETES CARE INC reported $1.01B in revenue while Medline Inc. reported $28.43B.
Full pages: TANDEM DIABETES CARE INC and Medline Inc., or browse the full rankings.